Ilyang Pharmaceutical Accelerates Rebuilding of "Wonbi-D" Exports to China

Ilyang Pharmaceutical has officially begun rebuilding its business in China by exporting the finished product of "Wonbi-D," a representative ginseng drink, through "Ilyang Pharmaceutical (Jilin) Co., Ltd." located in Changchun City, Jilin Province, China.

Ilyang Pharmaceutical has officially begun rebuilding its business in China by exporting the finished product 'Wonbi-D,' a representative ginseng drink, through 'Ilyang Pharmaceutical (Jilin) Co., Ltd.,' located in Changchun City, Jilin Province, China. Ilyang Pharmaceutical

According to Ilyang Pharmaceutical on June 24, this export marks the company’s first business achievement following its final victory in a lawsuit over undistributed profits and management rights dispute with Qing Shan Industrial in China. This is a meaningful move that comes after Ilyang Pharmaceutical fully regained control and business leadership of "Ilyang Pharmaceutical (Jilin) Co., Ltd." It is considered the starting point for normalizing its business operations in China, as well as a critical turning point for establishing a stable management foundation and enhancing corporate value going forward.

In particular, a significant factor behind the rapid execution of this export was Ilyang Pharmaceutical’s acquisition of the "Wonbi-D" trademark rights, which substantially reduced the costs required for re-entering the Chinese market and dramatically accelerated the pace of business reconstruction.

Additionally, China is one of the world’s largest health functional food and pharmaceutical markets, and it continues to grow steadily. Trust in Korean pharmaceuticals and health functional foods is also increasing, so Ilyang Pharmaceutical’s expansion in the Chinese market centered on "Wonbi-D" is expected to have a positive impact on mid- to long-term revenue growth.

Meanwhile, "Wonbi-D" is a ginseng drink that was first developed in Korea in 1971 and, based on its excellent quality and efficacy, has remained a leading brand beloved by consumers both domestically and internationally for decades.

Ilyang Pharmaceutical has begun actively rebuilding its business in China by exporting the finished product 'Wonbi-D', a representative ginseng drink, through 'Ilyang Pharmaceutical (Jilin) Co., Ltd.' located in Changchun City, Jilin Province, China. Ilyang Pharmaceutical

Especially in the Chinese market, "Wonbi-D" enjoyed a second golden era thanks to its high recognition and popularity that surpassed even its home market. The excellent efficacy of authentic Korean ginseng, rigorous quality control, and distinctive product strength have made "Wonbi-D" a preferred choice among Chinese consumers.

Based on the excellence of Korean ginseng and the brand competitiveness of "Wonbi-D," Ilyang Pharmaceutical plans to accelerate the growth of "Ilyang Pharmaceutical (Jilin) Co., Ltd.," expand its competitiveness beyond China into the global market, and evolve into a world-class ginseng drink brand.

This content was produced with the assistance of AI translation services.